Genfit
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Parc Eurasanté 885 Avenue Eugène Avinée,...Phone Number
+33 320164000Website
www.genfit.comRevenue
$28.6 MillionStock Symbol
GNFTIndustry
About Genfit
Genfit Org Chart
Chief Technology Officer
Is Genfit your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Genfit, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Genfit recently announced quarterly report
Check if Genfit has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Genfit launches new products
Click to see if Genfit had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Genfit
Funding: Get notified immidiatlly once Genfit has new funding data
Website visits: Recent activity has been detected on your website
Check out if Genfit is spiking on competitors!
Recommended Actions
Find VP level buyers at Genfit
Find 3 more new buyers
Company Profile Activity
Activity Insights
Genfit is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Genfit is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Genfit.
Genfit financials insights
Gather financial insights about Genfit, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Share Placement
$15.5M
Share Placement
$5.4M
Share Placement
$22.7M
Share Placement
$36.6M
Share Placement
$48.2M
Debt
$194.5M
Stock Offering
$155.4M
Debt
$13.3M
Debt
$200M
Genfit Tech Stack
A closer look at the technologies used by Genfit
Most Recent Scoops
Genfit News & Media
GENFIT Annual General Meeting of June 15, 2026 - Shareholders' letter
Dear Shareholders,GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 25, 2026 – GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today highlights its broad participation at EASL Congress 2026. This visibility reflects both its scientific momentum and its active involvement in the ACLF ecosystem, as well as its position at an inflection point in MASH, while also highlighting the continuoGENFIT Reports First Quarter 2026 Financial Information and Provides a Corporate Update
Lille (France); Cambridge, (Massachusetts, United States); Zurich (Switzerland); May 21, 2026 - GENFIT (Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announces its cash position as of March 31, 2026 and revenues for the first three months of 20261 and provides a corporate update.GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents
GENFIT today announced that it published the notice of the Combined Shareholders Meeting
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genfit
Genfit, founded in 1999 and headquartered in Loos Hauts-de-France, is a bio-pharmaceutical company that develops therapeutic, and diagnostic solutions to meet needs in the field of metabolic and inflammatory disease.... Read More